Showing 1,681 - 1,700 results of 20,793 for search '"therapy"', query time: 0.12s Refine Results
  1. 1681
  2. 1682

    Maintenance Electroconvulsive Therapy in a Patient with Treatment-Resistant Paranoid Schizophrenia and Comorbid Epilepsy by Beppe Micallef-Trigona, Joseph Spiteri

    Published 2012-01-01
    “…The treatment of choice for acute schizophrenia is antipsychotic drug treatment and electroconvulsive therapy (ECT) and should only be considered as an option for treatment-resistant schizophrenia, where treatment with clozapine has already proven ineffective or intolerable. …”
    Get full text
    Article
  3. 1683

    Hyperbaric oxygen therapy attenuates heatstroke-induced hippocampal injury by inhibiting microglial pyroptosis by Ancong Xu, Fan Huang, Er Chen, Zhiqiang Zhang, Yanxuan He, Xichong Yu, Guoxin He

    Published 2024-12-01
    “…Hyperbaric oxygen (HBO) therapy prevents CNS injury in heatstroke mice. However, the underlying mechanisms of HBO in heatstroke-induced hippocampal injury remain unclear. …”
    Get full text
    Article
  4. 1684
  5. 1685

    Comparison of Nasal Cannulas and the OxyArm in Patients Requiring Chronic Domiciliary Oxygen Therapy by James Paul, Ted Otvos

    Published 2006-01-01
    “…OBJECTIVES: The present study was designed to compare the performance of a new oxygen delivery device, the OxyArm (OA) (Southmedic Inc, Canada), with a standard nasal cannula (NC) (Salter-Style 1600, Salter Labs, USA) for both oxygen delivery and patient preference in patients on long-term oxygen therapy (LTOT).…”
    Get full text
    Article
  6. 1686

    Photodynamic Therapy for Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis by Jiao Lin, Guangcheng Ni, Tingting Ding, Shangxue Lei, Liang Zhong, Na Liu, Keran Pan, Ting Chen, Xin Zeng, Hao Xu, Taiwen Li, Hongxia Dan

    Published 2021-01-01
    “…To assess the efficacy of photodynamic therapy (PDT) for oral squamous cell carcinoma (OSCC), literature on this topic from Embase, PubMed, and Web of Science were obtained and analyzed. …”
    Get full text
    Article
  7. 1687
  8. 1688

    Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy by Dustin E Loomes, Christopher Teshima, Philip Jacobs, Richard Fedorak

    Published 2011-01-01
    “…BACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.…”
    Get full text
    Article
  9. 1689
  10. 1690

    Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue by Nadimul Hoda, Aastha Moza, K.P. Amith, K.S. Sabitha

    Published 2024-06-01
    “…Our analysis consisted of both the forms of therapies where in immunotherapy precedes targeted therapy in terms of confirmed clinical trials. …”
    Get full text
    Article
  11. 1691

    Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes by Ana Sofia Lopes, Rita Basto, Susana Henriques, Luísa Colaço, Filomena Costa e Silva, Isabel Prieto, Francisco Guerreiro

    Published 2019-01-01
    “…To evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) in patients with acute retinal artery occlusion (RAO). …”
    Get full text
    Article
  12. 1692

    Low-Level Laser Therapy for Temporomandibular Disorders: A Systematic Review with Meta-Analysis by Gang-Zhu Xu, Jie Jia, Lin Jin, Jia-Heng Li, Zhan-Yue Wang, Dong-Yuan Cao

    Published 2018-01-01
    “…We systematically reviewed randomized controlled trials (RCTs) of the effect of low-level laser therapy (LLLT) versus placebo in patients with temporomandibular disorder (TMD). …”
    Get full text
    Article
  13. 1693

    The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease by Marcin Paprocki, Szymon Żwirowski, Krzysztof Kuziemski

    Published 2025-01-01
    “…Other primary care specialists treated the control group (CG) (n = 37) in the same outpatient clinic; antibiotic therapies were implemented at the physician’s discretion, most often using Anthonisen’s criteria. …”
    Get full text
    Article
  14. 1694
  15. 1695

    Use of Percutaneous Ethanol Injection Therapy for Recurrent Secondary Hyperparathyroidism after Subtotal Parathyroidectomy by Walter G. Douthat, Gabriela Cardozo, Gabriela Garay, Santiago Orozco, Carlos Chiurchiu, Jorge de la Fuente, Javier de Arteaga, Pablo U. Massari

    Published 2011-01-01
    “…We evaluated the efficacy of percutaneous ethanol injection therapy (PEIT) as a therapeutic option for recurrence of secondary hyperparathyroidism after subtotal parathyroidectomy in ESRD patients. …”
    Get full text
    Article
  16. 1696
  17. 1697
  18. 1698

    Ambulatory Intravenous Antibiotic Therapy in Quebec: The Hôpital Charles LeMoyne Experience in 1996 by Laurent Delorme, Charles Frenette, Isabelle Le Corre, Julie Duchesne, Carole Delorme, Pauline Plourde

    Published 2000-01-01
    “…Two types of patients can benefit from an outpatient intravenous antibiotic therapy program. One group of patients needs empirical short term therapy and can be switched to oral sequential therapy after two to five days of outpatient intravenous antibiotic therapy. …”
    Get full text
    Article
  19. 1699
  20. 1700

    Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies by Cui Y, Liu X, Feng S

    Published 2025-02-01
    “…Early and appropriate empirical therapy significantly improves outcomes in FN, reducing hospital stays and healthcare costs. …”
    Get full text
    Article